MedTrace Logo

(VIII): The Eight Study and Immunologic Response Sub-study

NCT05237024 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2022-02-11

No results posted yet for this study

Summary

The study's objective is to test the hypothesis that immune system activation and subsequent systemic inflammation can be detected through continuously tracking multiple bio signals including physiologic variables (ECG, skin temperature and their derivatives) and behavioral variables (activity and sleep from accelerometers) collected during routine activities of daily living using wearable biosensors. In the sub-study, the objective is to explore the association between these objectively measured physiologic changes and vaccine-induced humoral and T-cell responses.

Conditions

  • Vaccine Reaction

Sponsors & Collaborators

  • physIQ, Inc.

    lead INDUSTRY

Principal Investigators

  • Steve Steinhubl, MD · CMO

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2022-07-15
Completion
2022-12-15

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05237024 on ClinicalTrials.gov